Free NEONATAL PEDIATRIC TRANSPORT EXAMINATION Practice Questions

Sample Practice Questions

Try these 10 sample questions from the NEONATAL PEDIATRIC TRANSPORT EXAMINATION practice bank. Each includes the answer and explanation. Continue with the interactive practice above to review the full question set.

1. 1An emergency physician asks whether a child with an emergency medical condition is stabilized for an interfacility transfer under EMTALA. Which finding meets the regulatory definition?

   1. A. The child's laboratory values have returned to age-adjusted reference ranges.
   2. B. Material deterioration is unlikely, within reasonable medical probability, during transfer.
   3. C. The child has completed the definitive treatment planned for the underlying disease.
   4. D. The child's vital signs have returned to the values recorded before the illness.

   Answer: B

   Explanation: The definition states that "no material deterioration of the condition is likely, within reasonable medical probability, to result from or occur during the transfer". Stabilization is assessed against the risk of deterioration during transfer, rather than normalization of tests, completion of treatment, or return to baseline.

   Reference: 42 CFR § 489.24 — Special Responsibilities of Medicare Hospitals in Emergency Cases — § 489.24(b), definition of Stabilized

2. 2A very preterm newborn has respiratory distress syndrome. Which pulmonary abnormality directly promotes alveolar collapse and increased breathing effort?

   1. A. Delayed clearance of fetal fluid from the air spaces.
   2. B. Persistently elevated pulmonary vascular resistance.
   3. C. Deficient pulmonary surfactant within immature air spaces.
   4. D. Obstruction of the airway by aspirated meconium.

   Answer: C

   Explanation: NHLBI states: "RDS is caused by a lack of surfactant in the lungs." Deficient surfactant promotes alveolar collapse and increased breathing effort. Delayed fluid clearance, persistent pulmonary vascular resistance, and meconium obstruction are genuine neonatal respiratory mechanisms, but do not define surfactant-deficient RDS.

   Reference: NHLBI — Newborn Breathing Conditions: Respiratory Distress Syndrome — What Causes RDS?

3. 3A child has an acute asthma exacerbation with reversible airflow obstruction. Which inhaled drug class provides rapid initial bronchodilation?

   1. A. Inhaled corticosteroid
   2. B. Short-acting beta2-agonist
   3. C. Long-acting muscarinic antagonist
   4. D. Inhaled mast-cell stabilizer

   Answer: B

   Explanation: NHLBI recommends "SABA to relieve airflow obstruction" in urgent exacerbation management. A short-acting beta2-agonist is the rapid reliever; the other classes do not replace initial rescue bronchodilation.

   Reference: NHLBI EPR-3 — Managing Exacerbations of Asthma — p.373, urgent medical care

4. 4A child with an unstabilized emergency medical condition needs care unavailable at a Medicare-participating hospital. The parent has not requested transfer, and the physician is present. What determination must the physician certify before an otherwise appropriate transfer?

   1. A. The anticipated receiving-hospital benefits outweigh the increased risks of transfer.
   2. B. The receiving hospital can eliminate the increased medical risks of the transfer.
   3. C. The transport-related risks are less than the child's risks before any treatment.
   4. D. The receiving hospital's treatment has a greater likelihood of success than failure.

   Answer: A

   Explanation: The physician must certify that "the medical benefits reasonably expected from the provision of appropriate medical treatment at another medical facility outweigh the increased risks". This is a comparison of anticipated benefits with increased transfer risks; it does not require risk elimination or a particular probability of treatment success.

   Reference: 42 CFR § 489.24 — Special Responsibilities of Medicare Hospitals in Emergency Cases — § 489.24(e)(1)(ii)(B)

5. 5An early-term infant delivered by cesarean without labor has tachypnea attributed to delayed clearance of fetal lung fluid after other serious causes are excluded. Which diagnosis fits this mechanism?

   1. A. Transient tachypnea of the newborn
   2. B. Respiratory distress syndrome
   3. C. Bronchopulmonary dysplasia
   4. D. Persistent pulmonary hypertension

   Answer: A

   Explanation: NHLBI explains that fetal lung fluid sometimes "does not go away as quickly as it should. This causes TTN." The retained-fluid mechanism and cesarean-without-labor history support TTN rather than surfactant deficiency, chronic lung injury, or persistent pulmonary vascular resistance.

   Reference: NHLBI — Newborn Breathing Conditions: Types — Transient Tachypnea of the Newborn

6. 6A child with severe asthma becomes exhausted and has little audible wheezing despite marked respiratory distress and poor air entry. Which degree of obstruction can this quieter chest represent?

   1. A. Mild residual airway obstruction
   2. B. Moderate persistent airway obstruction
   3. C. Extremely severe airway obstruction
   4. D. Fully reversed airway obstruction

   Answer: C

   Explanation: NHLBI warns that "extremely severe obstruction may be accompanied by a" silent chest. Reduced wheeze with poor air entry may therefore reflect critically restricted airflow. The sound reduction must not be mistaken for mild, moderate, or fully reversed obstruction.

   Reference: NHLBI EPR-3 — Managing Exacerbations of Asthma — p.391, initial physical examination

7. 7During an appropriate EMTALA transfer, the team sends all available emergency records with a neonate. A diagnostic result becomes available after departure. When must the transferring hospital send that result to the receiving facility?

   1. A. After receiving a written records request from the receiving clinician.
   2. B. After obtaining a separate written disclosure authorization from the parent.
   3. C. As soon as practicable after the patient's transfer.
   4. D. After completing the final discharge summary for the transferred encounter.

   Answer: C

   Explanation: The regulation states: "Other records (e.g., test results not yet available or historical records not readily available from the hospital's files) must be sent as soon as practicable after transfer". The newly available result must be forwarded promptly. A separate records request, disclosure authorization, or finalized discharge summary is not the timing trigger specified for these transfer records.

   Reference: 42 CFR § 489.24 — Special Responsibilities of Medicare Hospitals in Emergency Cases — § 489.24(e)(2)(iii)

8. 8A premature infant with established RDS continues to struggle despite nCPAP. Which therapy specifically replaces the deficient material responsible for this lung disorder?

   1. A. Inhaled nitric oxide therapy
   2. B. Systemic corticosteroid therapy
   3. C. Intravenous caffeine therapy
   4. D. Pulmonary surfactant replacement

   Answer: D

   Explanation: NHLBI states: "Surfactant replacement therapy: This can be used if a newborn struggles to breathe despite the use of nCPAP." It replaces the deficient alveolar material; the other therapies have different targets.

   Reference: NHLBI — Newborn Breathing Conditions: Respiratory Distress Syndrome — How Is RDS Treated?

9. 9After an hour of intensive conventional therapy, a child's asthma exacerbation remains severe. Which intravenous adjunct may be considered while preparing for escalation if needed?

   1. A. Magnesium sulfate
   2. B. Calcium gluconate
   3. C. Sodium bicarbonate
   4. D. Potassium chloride

   Answer: A

   Explanation: NHLBI states: "Consider intravenous magnesium sulfate in patients who have life-threatening exacerbations" and those remaining severe after an hour of intensive treatment. It is an adjunct; necessary intubation must not be delayed.

   Reference: NHLBI EPR-3 — Managing Exacerbations of Asthma — p.399, Impending Respiratory Failure, Intravenous magnesium sulfate

10. 10At a Medicare-participating emergency department, a parent refuses an offered appropriate transfer for a child after discussion of its risks and benefits. What should the clinician seek to document under EMTALA?

    1. A. Written consent acknowledging the risks of the proposed transfer.
    2. B. Written refusal acknowledging risks and benefits and giving the reasons for refusal.
    3. C. Physician certification that anticipated transfer benefits exceed the increased risks.
    4. D. Receiving-facility confirmation of available space and acceptance of the transfer.

    Answer: B

    Explanation: For refusal of transfer, "The written document must indicate the person has been informed of the risks and benefits of the transfer and state the reasons for the individual's refusal." The clinician should seek informed written refusal. Transfer consent, risk-benefit certification, and receiving-facility acceptance serve different regulatory functions.

    Reference: 42 CFR § 489.24 — Special Responsibilities of Medicare Hospitals in Emergency Cases — § 489.24(d)(5)